Skip Nav Destination
The FDA Outlook of Events Reporting after Ticagrelor or Clopidogrel in the PLATO Trial: Impact of Sponsor Censoring Dates, Drug Discontinuation, and Withdrawal of Consent
Cardiology (2012) 120 (3): 169–171.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Patrizia Natale
- Suetonia C Palmer
- Valeria M Saglimbene
- Marinella Ruospo
- Mona Razavian
- Jonathan C Craig
- Meg J Jardine
- Angela C Webster
- Giovanni FM Strippoli
Cochrane Database of Systematic Reviews (2022) 2022 (2)
